STAT+: Congress considers a longer phase-out of looser, Covid-era telehealth policies
WASHINGTON — Lawmakers are considering extending the more flexible telehealth policies put in place during the…
Category: Politics
STAT+: Key Democrat moves to crack down on FDA accelerated approvals
WASHINGTON – A powerful Democratic lawmaker has introduced a bill that would dramatically rein in…
.jpg)
White House transparency disputes imperil funds to buy Covid therapeutics
WASHINGTON — The White House hasn’t publicly detailed exactly how it’s spent the more than…
As Omicron recedes, White House shifts to a more targeted Covid strategy
WASHINGTON — The threat of the Omicron variant is receding and cities around the country…
In State of the Union, Biden walks a fine line on Covid optimism
WASHINGTON — President Biden on Tuesday vowed that the U.S. won’t become complacent in its…
STAT+: Pfizer made Trump’s vaccine push harder than it needed to be, former Warp Speed official alleges in new book
WASHINGTON — Pfizer may have been the first company to deliver on the promises of…
Robert Califf is a fervent believer in data. At the FDA, will that be enough?
At his confirmation hearing last month to lead the Food and Drug Administration, Robert Califf…
STAT+: Some drug makers quietly resumed donations to lawmakers who denied Biden’s election victory
Four major drug makers each donated tens of thousands of dollars last year to Republican…
Covid-19 politics force state lawmakers to ponder pharma campaign cash
WASHINGTON — Ohio state Rep. Beth Liston had accepted campaign donations from Pfizer before, but…
STAT+: FDA’s vaccines and biologics chief talks Covid-19, 2022 priorities, and getting back to gene, cell therapy review
WASHINGTON — No part of the Food and Drug Administration has been challenged by the…
STAT+: 3 contentious decisions the FDA will make in 2022
WASHINGTON — It’s going to be a bumpy 2022 for the Food and Drug Administration….
White House to buy, ship 500 million rapid tests for free beginning in January
The White House will buy and distribute 500 million rapid Covid-19 tests for free beginning…
Califf sails through confirmation hearing for FDA job, despite tensions over opioids
WASHINGTON — Robert Califf escaped largely unscathed from a two-hour hearing Tuesday vetting him to…
STAT+: Oregon wants to get out of covering drugs like Aduhelm in Medicaid
WASHINGTON — Oregon is gearing up to ask the Biden administration if its Medicaid program…
.jpg)
STAT+: Hospital, physician lobbies sue Biden administration over surprise billing regulation
WASHINGTON — The nation’s largest hospital and physician lobbying groups are suing the Biden administration…
STAT+: Major telehealth players unite ahead of tough lobbying battle
WASHINGTON — Major players in the telehealth space have united to create a supergroup of…
STAT+: As Biden touts his effort to cap insulin prices, advocates push for an even more ambitious reform
WASHINGTON — President Biden promised Monday that Democrats’ signature drug pricing plan will mean no…
Califf, nominee to lead FDA, asks Woodcock to stay in leadership role if he’s confirmed
WASHINGTON — Robert Califf, President Biden’s pick to lead the Food and Drug Administration, has…
STAT+: Hospitals and doctors fail to stop end-of-year Medicare cuts, for now
WASHINGTON — Hospitals and physicians lost a lobbying battle to stave off Medicare cuts of…
Biden’s new Covid plan: more boosters, free home testing, and ‘monoclonal antibody strike teams’
WASHINGTON — President Joe Biden will announce a new plan this afternoon for combating the…
7 policies in Biden’s spending plan aimed at health equity
WASHINGTON — Democrats have made big promises to tackle racial inequities across society, including in…
STAT+: Califf, Biden’s pick to lead FDA, has millions invested in pharma and tech companies
WASHINGTON — Robert Califf, President Biden’s choice to lead the Food and Drug Administration, earned…
Democrats’ major drug pricing reforms clear a hurdle in the House
WASHINGTON — House Democrats Friday broke a monthslong logjam and advanced prescription drug pricing reform…
STAT+: Former DARPA director: Biden’s new science agency should be independent, not an NIH office
WASHINGTON — The former director of DARPA, the Pentagon’s high-stakes research arm, says that for…
Moderate Democrats are still seeking changes to the party’s drug pricing package
WASHINGTON — Rep. Kurt Schrader, the Oregon Democrat who has played an outsized role in…
GOP opposition to vaccine mandates extends far beyond Covid-19
WASHINGTON — Right-wing politicians’ resistance to vaccine mandates is extending far beyond Covid-19 immunizations, a…
Biden taps Califf to helm FDA — an agency where he has plenty of unfinished business
WASHINGTON — Robert Califf, President Biden’s new pick to lead the Food and Drug Administration,…
STAT+: STAT+ Conversation: Drug pricing drama
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
How Nancy Pelosi almost killed drug pricing reform
WASHINGTON — The White House stunned health care experts last month when it declared it was…
Rochelle Walensky said she’d ‘fix’ the CDC, but nine months in, she’s faltering
WASHINGTON — Operating via Zoom from her home office in Newton, Mass., Rochelle Walensky is…
White House delays Covid-19 vaccine mandates for federal employees, contractors
The White House is delaying its mandate for federal workers and contractors to get vaccinated…
Here’s who wins and loses in Democrats’ new prescription drug pricing deal
WASHINGTON — Congressional Democrats on Tuesday announced they had agreed to a broad plan to overhaul…
Democrats circulate a new drug pricing outline with a big carveout for small biotechs
WASHINGTON — A proposed version of drug pricing legislation circulating among Capitol Hill aides and…
Here’s where Democrats’ resurrected drug pricing talks are headed
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
STAT+: Could Robert Califf’s ties to tech complicate his FDA nomination?
WASHINGTON — Robert Califf spent his first confirmation hearing explaining his entanglements with the drug…
Can a pro-Covid vaccine, anti-mandate position help a Republican win in a Democratic state?
Glenn Youngkin is playing both sides on Covid-19 vaccines. In his effort to win Virginia’s…
STAT+: Here’s how Biden can address high drug prices, without help from Congress
WASHINGTON — If President Biden wants major pharmaceutical industry reforms, he may have to achieve…
Pelosi working to gather support for last-minute, last-ditch drug pricing policy
WASHINGTON — House Speaker Nancy Pelosi’s office is working to gather support for a last-ditch…
STAT+: Biden abandons his push to lower drug prices
WASHINGTON — The White House is abandoning every single policy idea aimed at lowering prescription…
STAT+: Democratic senators raise concerns with potential FDA pick
WASHINGTON — Sens. Joe Manchin and Richard Blumenthal have concerns with President Biden’s rumored nominee…
Congress has bipartisan support to try to deal with the next pandemic. But those talks are already falling behind
WASHINGTON — Addressing the federal government’s failures during the Covid-19 pandemic has fallen off the…
Drug pricing talks heat up as Democrats work to win over skeptics
WASHINGTON — As drug pricing talks in Congress heated up this week, Democrats started negotiating…
STAT+: The four senators who could make or break Democrats’ drug pricing ambitions
WASHINGTON — The fate of the Democratic party’s ambitious goal of allowing Medicare to negotiate…
STAT+: Senate Democrats push back on the notion that adding dental, vision to Medicare would bankrupt it
Key Senate Democrats used a hearing Wednesday to push back on the argument that expanding…
Elizabeth Warren on over-the-counter hearing aids, health lobbying, and the FDA’s independence
WASHINGTON — On Tuesday the Food and Drug Administration took a major step toward allowing…
STAT+: Underpinning Sinema’s outspoken opposition to major drug pricing reforms: her close ties to Arizona biotechs
Phoenix, Ariz. is no Kendall Square. Its biotech companies, ventures like OncoMyx Therapeutics and VisionGate,…
STAT+: Amazon is beefing up its health care lobbying operation
WASHINGTON — Amazon is bulking up its efforts to influence health care policy at the…
STAT+: Is Robert Califf a savvy choice to helm the FDA — again?
WASHINGTON — The Food and Drug Administration has been without a permanent leader for 10…
STAT+: In its search for a new FDA commissioner, the White House is relying on insiders for advice
WASHINGTON — Ten months into his tenure, President Biden has yet to nominate anyone to…
Francis Collins’ resignation could complicate the fight over funding for ARPA-H
WASHINGTON — Francis Collins’ announcement last week that he will soon step down as National…